세계의 터너 증후군 시장 보고서(2025년)

Turner Syndrome Global Market Report 2025

US $ 4,490 ￦ 6,272,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,065,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,859,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

터너 증후군 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 7.7%의 연평균 복합 성장률(CAGR)로 34억 2,000만 달러에 달할 것으로 예측됩니다. 예측 기간의 성장은 X 염색체 구조 이상 사례 증가, 에스트로겐 대체 요법의 보급, 질병 진단을 위한 염색체 마이크로어레이 분석(CMA)의 사용 증가, 여성 인구 증가, 연구개발 활동의 확대 등에 기인하는 것으로 보입니다. 이 기간의 주요 동향으로는 신기술 채택, 제품 출시, 성장호르몬 치료의 발전, 호르몬 치료에 대한 수요 증가, 신규 치료법 개발 등을 들 수 있습니다.

여성 인구 증가는 터너 증후군 치료 시장의 성장을 견인할 것으로 예측됩니다. 평균 수명 연장, 의료 서비스 향상, 인구 통계학적 변화 등의 요인으로 인해 전 세계 여성 인구가 증가함에 따라 터너 증후군의 전문적인 치료에 대한 수요가 증가할 것으로 예측됩니다. 터너 증후군 치료는 키 성장을 위한 성장 호르몬 요법, 사춘기 유도 및 뼈 건강 유지를 위한 에스트로겐 보충, 관련 질환을 관리하기 위한 다학제적 치료를 통해 환자들을 지원합니다. 미국 인구조사국에 따르면, 2022년 7월 현재 미국에는 약 1억 6,800만 명의 여성이 있으며, 85세 이상 여성은 190만 명 증가했습니다. 또한 CEIC 데이터는 2022년 12월에 15-64세 여성 수가 2021년 294만 645명에서 2022년 295만 1,856명으로 증가했다고 보고했습니다. 이러한 인구 통계학적 특성은 터너 증후군 치료에 대한 수요 증가에 기여하고 있습니다.

소아 성장 호르몬 치료의 발전도 시장 성장의 원동력이 되고 있습니다. 주요 제약회사들은 터너 증후군 및 성장 관련 장애를 가진 어린이의 키 성장 결과와 전반적인 발달을 개선하기 위한 혁신적인 제품을 개발하기 위해 임상시험을 진행하고 있습니다. 소아 성장호르몬제, 특히 합성 또는 유전자 재조합 호르몬은 결핍증 아동의 성장을 가속하는 데 중요한 역할을 합니다. 예를 들어, 2024년 12월, Ascendis Pharma A/S는 1-10세 터너 증후군 아동을 대상으로 한 TransCon hGH(lonapegsomatropin)의 임상 2상 시험에서 좋은 결과를 발표했습니다. 이 임상시험에서 TransCon hGH는 유사한 안전성 프로파일과 함께 매일 복용하는 소마트로핀과 동등한 성장 개선 효과가 있는 것으로 입증됐습니다. 이러한 유망한 결과는 터너 증후군 환자들을 위한 성장 호르몬 치료 시장을 확대할 수 있을 것으로 기대됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 터너 증후군 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 터너 증후군 시장 : 성장률 분석
• 세계의 터너 증후군 시장 실적 : 규모와 성장, 2019-2024
• 세계의 터너 증후군 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 터너 증후군 전체 시장(TAM)

제6장 시장 세분화

• 세계의 터너 증후군 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 클래식 터너 증후군
• 모자이크 터너 증후군
• 세계의 터너 증후군 시장 : 치료 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 성장호르몬 요법
• 에스트로겐 및 프로게스테론
• 보충 요법
• 기타 치료법
• 세계의 터너 증후군 시장 : 약제 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Norditropin
• Oxandrolone
• Humatrope
• Somatropin
• Oxandrin
• Genotropin
• Nutropin
• Zomacton
• 세계의 터너 증후군 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 홈케어
• 전문 클리닉
• 외과 센터
• 기타 최종사용자
• 세계의 터너 증후군 시장: 클래식 터너 증후군별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Complete Monosomy X
• X Chromosome Deletion
• 세계의 터너 증후군 시장 : 모자이크 터너 증후군 세분화(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Mosaicism With 45,X/46,XX Karyotype
• Mosaicism With 45,X/46,XY Karyotype

제7장 지역별/국가별 분석

• 세계의 터너 증후군 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 터너 증후군 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 터너 증후군 시장 : 경쟁 구도
• 터너 증후군 시장 : 기업 개요
  • Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
  • AstraZeneca Plc : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• LG Chem Ltd.
• Eli Lilly and Company
• Novo Nordisk
• Merck KGaA
• Teva Pharmaceutical Industries Ltd.
• Sandoz International GmbH
• Genentech Inc.
• Ipsen Pharma
• Ferring Pharmaceutical
• BioMarin Pharmaceutical Inc.
• United Imaging Healthcare Co. Ltd.
• Daewoong Pharmaceutical Co. Ltd.
• OPKO Health Inc.
• Hanmi Pharmaceutical Co. Ltd.
• Dong-A ST Co. Ltd.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 터너 증후군 시장(2029년) : 새로운 기회를 제공하는 국가
• 터너 증후군 시장(2029년) : 새로운 기회를 제공하는 부문
• 터너 증후군 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Turner syndrome is a genetic condition affecting females, caused by the partial or complete absence of one X chromosome. It can lead to various developmental and medical challenges, including short stature, delayed puberty, infertility, heart defects, and certain learning difficulties. Diagnosis is typically performed through karyotype testing, and management involves specialized medical care to address associated health concerns.

The main types of Turner syndrome include classical Turner syndrome and mosaic Turner syndrome. Classical Turner syndrome is the most common form, characterized by the complete absence of one X chromosome in females. Treatment options include growth hormone therapy, estrogen and progesterone replacement therapy, and other supportive therapies. Several drugs are used for this condition, including Norditropin, Oxandrolone, Humatrope, Somatropin, Oxandrin, Genotropin, Nutropin, and Zomacton. These treatments are utilized by various end users, such as hospitals, home care settings, specialty clinics, and surgical centers.

The turner syndrome market research report is one of a series of new reports from The Business Research Company that provides turner syndrome market statistics, including turner syndrome industry global market size, regional shares, competitors with a turner syndrome market share, detailed turner syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the turner syndrome industry. This turner syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The turner syndrome market size has grown strongly in recent years. It will grow from $2.36 billion in 2024 to $2.55 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing awareness of women's health, rising healthcare expenditure, the expansion of the healthcare sector, greater awareness and early diagnosis of Turner syndrome, and public awareness initiatives.

The turner syndrome market size is expected to see strong growth in the next few years. It will grow to $3.42 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to the rising cases of structural abnormalities of the X chromosome, the widespread adoption of estrogen replacement therapy, the increasing use of chromosomal microarray analysis (CMA) for disease diagnosis, a growing female population, and expanding research and development activities. Key trends during this period include the adoption of new technologies, product launches, advancements in growth hormone therapy, rising demand for hormonal treatments, and the development of novel therapies.

The increasing female population is expected to drive the growth of the Turner syndrome treatment market. As the global female population expands due to factors such as higher life expectancy, improved healthcare, and demographic shifts, the demand for specialized treatments for Turner syndrome rises. Turner syndrome treatment supports affected individuals through growth hormone therapy to enhance stature, estrogen replacement for puberty induction and bone health maintenance, and multidisciplinary care to manage associated conditions. According to the U.S. Census Bureau, as of July 2022, the United States had approximately 168 million females, with 1.9 million more women aged 85 and older. Additionally, CEIC Data reported in December 2022 that the number of females aged 15-64 had risen from 2,940,645 in 2021 to 2,951,856 in 2022. This demographic trend is contributing to the increased demand for Turner syndrome treatments.

Advancements in pediatric growth hormone therapies are also driving market growth. Major pharmaceutical companies are conducting clinical trials to develop innovative products aimed at improving height outcomes and overall development in children with Turner syndrome and growth-related disorders. Pediatric growth hormone medications, particularly synthetic or recombinant hormones, play a crucial role in stimulating growth in children with deficiencies. For instance, in December 2024, Ascendis Pharma A/S announced positive Phase 2 trial results for TransCon hGH (lonapegsomatropin) in children aged 1-10 years with Turner syndrome. The trial demonstrated that TransCon hGH provided growth improvements comparable to daily somatropin, with a similar safety profile. These promising results could expand the market for growth hormone treatments in Turner syndrome patients.

In December 2024, Double Point Ventures (DPV) acquired Lumos Pharma for $38 million to enhance its portfolio in biopharmaceutical therapeutics for rare diseases. Lumos Pharma's lead candidate, LUM-201, an oral growth hormone secretagogue currently in Phase 2 clinical trials for pediatric growth hormone deficiency, has the potential to impact Turner syndrome treatment. By integrating Lumos Pharma's expertise, DPV aims to drive further innovation in growth hormone therapy and broaden treatment options for patients with Turner syndrome.

Major players in the turner syndrome market are Pfizer Inc., Sanofi SA, AstraZeneca Plc, Abbott Laboratories, Novartis AG, LG Chem Ltd., Eli Lilly and Company, Novo Nordisk, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Genentech Inc., Ipsen Pharma, Ferring Pharmaceutical, BioMarin Pharmaceutical Inc., United Imaging Healthcare Co. Ltd., Daewoong Pharmaceutical Co. Ltd., OPKO Health Inc., Hanmi Pharmaceutical Co. Ltd., Dong-A ST Co. Ltd., GeneScience Pharmaceuticals Co. Ltd., Ascendis Pharma, AnkeBio Co. Ltd., Biopartners Inc., Kexing Biopharm Co. Ltd.

North America was the largest region in the turner syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in turner syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the turner syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The turner syndrome market consists of revenues earned by entities by providing services such as genetic counseling, diagnostic testing services, fertility and reproductive health support. The market value includes the value of related goods sold by the service provider or included within the service offering. The turner syndrome market also includes sales of genetic testing kits, cardiac monitoring devices and bone density supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Turner Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on turner syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for turner syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The turner syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Classical Turner Syndrome; Mosaic Turner syndrome
• 2) By Therapy Type: Growth Hormone Therapy; Estrogen And Progesteron; Replacement Therapy; Other Therapy Types
• 3) By Drug Type: Norditropin; Oxandrolone; Humatrope; Somatropin; Oxandrin; Genotropin; Nutropin; Zomacton
• 4) By End-User: Hospitals; Homecare; Specialty Clinics; Surgical Centres; Other End-Users
• Subsegments:
• 1) By Classical Turner Syndrome: Complete Monosomy X; X Chromosome Deletion
• 2) By Mosaic Turner Syndrome: Mosaicism With 45,X/46,XX Karyotype; Mosaicism With 45,X/46,XY Karyotype
• Companies Mentioned: Pfizer Inc.; Sanofi SA; AstraZeneca Plc; Abbott Laboratories; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Turner Syndrome Market Characteristics

3. Turner Syndrome Market Trends And Strategies

4. Turner Syndrome Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Turner Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Turner Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Turner Syndrome Market Growth Rate Analysis
• 5.4. Global Turner Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Turner Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Turner Syndrome Total Addressable Market (TAM)

6. Turner Syndrome Market Segmentation

• 6.1. Global Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Classical Turner Syndrome
• Mosaic Turner syndrome
• 6.2. Global Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Growth Hormone Therapy
• Estrogen And Progesteron
• Replacement Therapy
• Other Therapy Types
• 6.3. Global Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Norditropin
• Oxandrolone
• Humatrope
• Somatropin
• Oxandrin
• Genotropin
• Nutropin
• Zomacton
• 6.4. Global Turner Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Surgical Centres
• Other End-Users
• 6.5. Global Turner Syndrome Market, Sub-Segmentation Of Classical Turner Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Complete Monosomy X
• X Chromosome Deletion
• 6.6. Global Turner Syndrome Market, Sub-Segmentation Of Mosaic Turner Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mosaicism With 45,X/46,XX Karyotype
• Mosaicism With 45,X/46,XY Karyotype

7. Turner Syndrome Market Regional And Country Analysis

• 7.1. Global Turner Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Turner Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Turner Syndrome Market

• 8.1. Asia-Pacific Turner Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Turner Syndrome Market

• 9.1. China Turner Syndrome Market Overview
• 9.2. China Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Turner Syndrome Market

• 10.1. India Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Turner Syndrome Market

• 11.1. Japan Turner Syndrome Market Overview
• 11.2. Japan Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Turner Syndrome Market

• 12.1. Australia Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Turner Syndrome Market

• 13.1. Indonesia Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Turner Syndrome Market

• 14.1. South Korea Turner Syndrome Market Overview
• 14.2. South Korea Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Turner Syndrome Market

• 15.1. Western Europe Turner Syndrome Market Overview
• 15.2. Western Europe Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Turner Syndrome Market

• 16.1. UK Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Turner Syndrome Market

• 17.1. Germany Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Turner Syndrome Market

• 18.1. France Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Turner Syndrome Market

• 19.1. Italy Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Turner Syndrome Market

• 20.1. Spain Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Turner Syndrome Market

• 21.1. Eastern Europe Turner Syndrome Market Overview
• 21.2. Eastern Europe Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Turner Syndrome Market

• 22.1. Russia Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Turner Syndrome Market

• 23.1. North America Turner Syndrome Market Overview
• 23.2. North America Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Turner Syndrome Market

• 24.1. USA Turner Syndrome Market Overview
• 24.2. USA Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Turner Syndrome Market

• 25.1. Canada Turner Syndrome Market Overview
• 25.2. Canada Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Turner Syndrome Market

• 26.1. South America Turner Syndrome Market Overview
• 26.2. South America Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Turner Syndrome Market

• 27.1. Brazil Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Turner Syndrome Market

• 28.1. Middle East Turner Syndrome Market Overview
• 28.2. Middle East Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Turner Syndrome Market

• 29.1. Africa Turner Syndrome Market Overview
• 29.2. Africa Turner Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Turner Syndrome Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Turner Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Turner Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Turner Syndrome Market Competitive Landscape
• 30.2. Turner Syndrome Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Turner Syndrome Market Other Major And Innovative Companies

• 31.1. LG Chem Ltd.
• 31.2. Eli Lilly and Company
• 31.3. Novo Nordisk
• 31.4. Merck KGaA
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Sandoz International GmbH
• 31.7. Genentech Inc.
• 31.8. Ipsen Pharma
• 31.9. Ferring Pharmaceutical
• 31.10. BioMarin Pharmaceutical Inc.
• 31.11. United Imaging Healthcare Co. Ltd.
• 31.12. Daewoong Pharmaceutical Co. Ltd.
• 31.13. OPKO Health Inc.
• 31.14. Hanmi Pharmaceutical Co. Ltd.
• 31.15. Dong-A ST Co. Ltd.

32. Global Turner Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Turner Syndrome Market

34. Recent Developments In The Turner Syndrome Market

35. Turner Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 Turner Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Turner Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Turner Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료